Cargando…
Regulatory approval of photoimmunotherapy: photodynamic therapy that induces immunogenic cell death
In September 2020, the Japanese government approved cetuximab saratolacan (previously known as RM-1929, commercial name: Akalux) for the treatment of unresectable locally advanced or recurrent head and neck cancer. Cetuximab saratolacan is a chemical conjugate of the photosensitizer IR700 with cetux...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Taylor & Francis
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595598/ https://www.ncbi.nlm.nih.gov/pubmed/33178498 http://dx.doi.org/10.1080/2162402X.2020.1841393 |